Founded in 2010, Amethyst operates one of the largest independent networks of cancer treatment centres in Europe, with 19 centres across France, Poland, Romania, the UK, Italy, and Austria. The group delivers a comprehensive range of oncology services, primarily radiotherapy, and treats over 50,000 patients annually.
Amethyst has built a strong reputation among both the medical community (including circa one hundred doctors working in its centres) and its patients, supported by a team of over 500 highly skilled professionals. Its modern, well-invested infrastructure includes around 40 linear accelerators, the core technology used to deliver the most innovative radiotherapy treatments, positioning the group as one of the largest radiotherapy providers in Europe.
The radiotherapy market is highly resilient and non-cyclical and is expected to grow significantly in the coming years, driven by demographic trends and its increasing recognition as acost-effective, non-invasive cancer treatment with minimal side effects.
Edward Chandler, Founding Partner at Fremman Capital, commented: “Amethyst fits perfectly into our strategy of supportingmarket-leading providers of essential services. With our deep healthcare experience and international reach, we’re excited to work with Amethyst to accelerate growth and build a European champion in radiotherapy.”
Colin Clark, Partner & Head of Europe at The Rohatyn Group, commented: “Working with the founding shareholders and management, Amethyst delivered strong growth and transformed into a sizeable business on a European scale during TRG’s ownership period. It has been our pleasure to support Amethyst’s development and expand access to high quality oncology care across Europe.”
About Amethyst
Amethyst is a leading European cancer care provider, specialising in radiotherapy, chemotherapy, and diagnostic imaging. With a presence in six countries and a network of 19 centres, Amethyst delivershigh-quality, accessible oncology care to thousands of patients annually. The group works closely with public health systems and hospitals, operating underreimbursement-based frameworks to ensure the sustainable delivery of critical care.
For more information, please visit www.amethysthealthcare.com.
About Fremman Capital
Fremman Capital is a pan-European, mid-marketinvestment firm with offices in London, Luxembourg, Madrid, Munich, and Paris. The firm partners with successful management teams to help transform businesses into multinational sustainable leaders. Fremman Capital’s team brings over a century of combined investment experience, with a mission to foster sustainable business growth that positively impacts society.
For more information, please visit https://fremman.com.
About TRG
Founded in 2002, The Rohatyn Group is an asset management firm focused on emerging markets and real assets. Headquartered in New York the firm is comprised of ~150 professionals based in 16 countries across North and South America, Europe, the Middle East, Africa, India, Southeast Asia, and Oceania. Specializing in late-stage growth and capital buyouts, TRG’s regionally focused Private Equity teams generally pursuemid-market opportunities across various sectors in Latin America, Emerging Europe, India, and Africa.